Vital KSK Holdings (TSE:3151) ROCE % : 13.54% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Vital KSK Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vital KSK Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 13.54%.

Vital KSK Holdings ROCE % Historical Data

The historical data trend for Vital KSK Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vital KSK Holdings ROCE % Chart

Vital KSK Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

5.85

5.61

1.92

6.05

6.79

Vital KSK Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															5.82	13.24	4.84	7.01	13.54

Vital KSK Holdings ROCE % Calculation

Vital KSK Holdings's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	8207	/	( ( (313033 - 190092)	+	(297316 - 178659) )	/ 2 )
	=	8207	/	( (122941	+	118657)	/ 2 )
	=	8207	/	120799
	=	6.79 %

Vital KSK Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	16452	/	( ( (321745 - 199821)	+	(328344 - 207259) )	/ 2 )
	=	16452	/	( ( 121924	+	121085 )	/ 2 )
	=	16452	/	121504.5
	=	13.54 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Vital KSK Holdings (TSE:3151) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vital KSK Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Vital KSK Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vital KSK Holdings (TSE:3151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Vital KSK Holdings Inc (TSE:3151) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016

Website

http://www.vitalksk.co.jp

Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.

Vital KSK Holdings (TSE:3151) Headlines

No Headlines